Postoperative nausea and vomiting: current concepts, management strategies, and future perspectives
Open Access
- 11 September 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1930252
Abstract
Postoperative nausea and vomiting (PONV) remains one of the most common and distressing adverse events after anesthesia and surgery, with important effects on patient comfort, recovery quality, discharge readiness, and healthcare resource use. Although advances in anesthetic techniques, antiemetic pharmacology, and enhanced recovery pathways have improved perioperative care, PONV continues to occur frequently because of its multifactorial pathophysiology and variable individual susceptibility. This narrative review provides a clinically oriented overview of current concepts in PONV, including epidemiology, clinical burden, neurochemical mechanisms, risk factors, prediction models, baseline risk reduction, pharmacological prophylaxis, rescue treatment, postdischarge care and future perspectives. PONV results from complex interactions among central and peripheral emetic pathways, including gastrointestinal vagal afferents, the chemoreceptor trigger zone, vestibular input, higher cortical and limbic modulation, and multiple neurotransmitter systems such as serotonin, dopamine, histamine, acetylcholine, substance P, and opioid-mediated signaling. Structured risk assessment, particularly using simplified prediction tools such as the Apfel score, remains essential for guiding individualized prophylaxis. Preventive strategies should combine reduction of modifiable perioperative risk factors with appropriate multimodal antiemetic therapy. Key interventions include minimizing exposure to volatile anesthetics and nitrous oxide when suitable, using opioid-sparing analgesia, optimizing hydration and fasting practices, and integrating regional or neuraxial techniques when appropriate. Pharmacological management relies on agents targeting different receptor systems, including 5-HT3 receptor antagonists, dopamine receptor antagonists, neurokinin-1 receptor antagonists, glucocorticoids, anticholinergics, and antihistamines. Future research should improve prediction accuracy, clarify optimal prophylactic combinations, strengthen guideline implementation, evaluate postdischarge symptoms, and explore artificial intelligence-assisted individualized prevention. A comprehensive, risk-based, and patient-centered approach remains central to reducing the burden of PONV.Keywords
This publication has 165 references indexed in Scilit:
- Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting: a network meta-analysisCochrane Database of Systematic Reviews, 2025
- Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic OpportunitiesMedcomm, 2025
- Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysisCochrane Database of Systematic Reviews, 2020
- Supplemental perioperative intravenous crystalloids for postoperative nausea and vomitingCochrane Database of Systematic Reviews, 2019
- Cholinesterase inhibitors for rarer dementias associated with neurological conditionsCochrane Database of Systematic Reviews, 2015
- Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sicknessExperimental Brain Research, 2014
- Scopolamine (hyoscine) for preventing and treating motion sicknessCochrane Database of Systematic Reviews, 2011
- Eine faktorielle Studie von 6 Interventionen zur Vermeidung von belkeit und Erbrechen nach NarkosenDer Anaesthesist, 2005
- 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomitingCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- PERPHENAZINE AS AN ANTIEMETIC AGENT IN CANCER AND OTHER CHRONIC DISEASESJAMA, 1958